February 7, 2008 (Chicago, IL) - Doctors and regulators concerned about the spike in off-label patent foramen ovale (PFO) closure procedures now have some numbers to fall back on. A research letter ...

Bethesda, MD - A new single-center report of 100 cases of percutaneous closure of patent foramen ovales (PFOs) and atrial-septal defects (ASDs) shows excellent results in terms of defect closure, with ...

ORLANDO, FL—Three months of clopidogrel on top of aspirin appears to reduce the number and severity of migraines following atrial septal defect (ASD) closure, a new study suggests. The findings, while ...

FOUNTAIN VALLEY, CA and FRANKFURT, GERMANY., Prof. Dr. Horst Sievert of the Cardiovascular Center, Frankfurt, successfully completed five PFO closures using the NobleStitch™ EL-marking the official ...

Sahajanand Medical Technologies (SMT) is using its Cocoon Occluder devices to treat congenital heart defects like atrial septal defect and patent foramen ovale. These minimally invasive devices ...

Patients who have a heart defect known as patent foramen ovale incidentally discovered and repaired during surgery for a different condition may have an increased odds of postoperative stroke, along ...

Occlutech, a leading European developer of septum occluders such as PFO and ASD devices as well as other innovative, minimally invasive cardiac implants, today announced that it got a favorable ruling ...

Patients with simple coronary heart disease (CHD) who underwent CHD surgery had a lower risk for epilepsy than those who did not undergo surgery. HealthDay News — Among simple congenital heart ...